|Harnessing the immune system to improve cancer therapy|
NE Papaioannou, OV Beniata, P Vitsos, O Tsitsilonis, P Samara
Annals of translational medicine 4 (14), 2016
|Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy|
K Ioannou, P Samara, E Livaniou, E Derhovanessian, OE Tsitsilonis
Cancer Immunology, Immunotherapy 61 (5), 599-614, 2012
|Serum TNF-α, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil’s syndrome|
I Kyriakidis, P Samara, A Papa
Cytokine 54 (2), 117-120, 2011
|Polar Constituents of Marrubium thessalum Boiss. & Heldr. (Lamiaceae) and their Cytotoxic/Cytostatic Activity|
A Argyropoulou, P Samara, O Tsitsilonis, H Skaltsa
Phytotherapy Research 26 (12), 1800-1806, 2012
|Prothymosin α and a prothymosin α-derived peptide enhance TH 1-type immune responses against defined HER-2/neu epitopes|
K Ioannou, E Derhovanessian, E Tsakiri, P Samara, H Kalbacher, ...
BMC immunology 14 (1), 1-14, 2013
|Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights|
C Cheimonidi, P Samara, P Polychronopoulos, EN Tsakiri, T Nikou, ...
Redox biology 16, 169-178, 2018
|Prothymosin alpha and immune responses: are we close to potential clinical applications?|
P Samara, K Ioannou, OE Tsitsilonis
Vitamins and hormones 102, 179-207, 2016
|The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro|
P Samara, K Ioannou, M Neagu, N Arnogiannaki, A Ardavanis, W Voelter, ...
International immunopharmacology 15 (1), 50-57, 2013
|New semi-synthetic analogs of oleuropein show improved anticancer activity in vitro and in vivo|
P Samara, N Christoforidou, C Lemus, A Argyropoulou, K Ioannou, ...
European journal of medicinal chemistry 137, 11-29, 2017
|Expression of miR-208b and miR-499 in Greek patients with acute myocardial infarction|
K Agiannitopoulos, P Pavlopoulou, K Tsamis, K Bampali, P Samara, ...
in vivo 32 (2), 313-318, 2018
|Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α (100–109) in sera of mice infected with bacteria|
P Samara, H Kalbacher, K Ioannou, DL Radu, E Livaniou, VJ Promponas, ...
Journal of immunological methods 395 (1-2), 54-62, 2013
|Antiproliferative Activity of (-)-Rabdosiin Isolated from Ocimum sanctum L.|
A Flegkas, T Milosević Ifantis, C Barda, P Samara, O Tsitsilonis, H Skaltsa
Medicines 6 (1), 37, 2019
|Prothymosin alpha: an alarmin and more...|
P Samara, CE Karachaliou, K Ioannou, N E Papaioannou, I F Voutsas, ...
Current medicinal chemistry 24 (17), 1747-1760, 2017
|Specific in vitro binding of a new 99mTc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophils|
CE Karachaliou, C Liolios, C Triantis, C Zikos, P Samara, OE Tsitsilonis, ...
International journal of pharmaceutics 486 (1-2), 1-12, 2015
|Isolation, Identification and Cytotoxic Activity of Triterpenes and Flavonoids from Green Walnut (Juglans regia L.) Pericarps.|
G Tsasi, P Samara, O Tsitsilonis, G Jürgenliemk, H Skaltsa
Records of Natural Products 10 (1), 2016
|A cytokine cocktail augments the efficacy of adoptive NK-92 cell therapy against mouse xenografts of human cancer|
P Samara, M Skopeliti, ML Tsiatas, S Georgaki, C Gouloumis, W Voelter, ...
Anticancer research 36 (7), 3373-3382, 2016
|A flow cytometric approach for studying alterations in the cytoplasmic concentration of calcium ions in immune cells following stimulation with thymic peptides|
NE Papaioannou, IF Voutsas, P Samara, OE Tsitsilonis
Cellular immunology 302, 32-40, 2016
|miRNA polymorphisms and risk of premature coronary artery disease|
K Agiannitopoulos, P Samara, M Papadopoulou, A Efthymiadou, ...
Hellenic Journal of Cardiology, 2020
|1078 Prothymosin Alpha and Its Carboxy-terminal Decapeptide ProTalpha (100-109) Induce Th1-type Tumor-specific Immune Responses|
K Ioannou, E Derhovanessian, P Samara, IF Voutsas, H Kalbacher, ...
european journal of cancer, S259-S260, 2012
|A fragment of the alarmin prothymosin α as a novel biomarker in murine models of bacteria-induced sepsis|
P Samara, V Miriagou, M Zachariadis, O Mavrofrydi, VJ Promponas, ...
Oncotarget 8 (30), 48635, 2017